BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
BRAF
,
calcium channel activity
,
Diabetes mellitus
,
Prostate
,
Rosiglitazone
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Phosphodiesterase inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Broad Connectivity Map (CMAP 2.0) compound database
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Evolving management of pediatric pulmonary arterial hypertension: impact of phosphodiesterase inhibi…
The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphod…
Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction.
Docking-based CoMFA and CoMSIA analyses of tetrahydro-β-carboline derivatives as type-5 phosphodiest…
Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS)
Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
The Phosphodiesterase Inhibitor Pentoxifylline as an Adjuvant in Treatment of Negative Symptoms in C…
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ